Jaundice, Obstructive: Clinical Trials

2 trials for Jaundice, Obstructive, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated, 1 unknown. 2 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Terminated 1, Unknown 1
Phase 22Terminated 1, Unknown 1

Follow Jaundice, Obstructive: new trials by email Literature Review of Jaundice, Obstructive trials Research Report on Jaundice, Obstructive

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
SMOFlipid to Lessen the Severity of Neonatal Cholestasis
SMOFlipid - Cholestasis, Jaundice, Obstructive
Phase 1 / Phase 2TerminatedUniversity of Florida22016-05-012017-04-17
Cholinergic Anti-inflammatory Pathway in Prevention & Treatment of the SIRS in Patients With Jaundice After Operation.
neostigmine methylsulfate,raceanisodamine hydrochloride - Systemic Inflammatory Response Syndrome, Jaundice, Obstructive
Phase 1 / Phase 2UnknownWanqing Gu1002014-08-012014-10-30

Narrower conditions

Cholestasis (1)  ·  Enterocolitis, Necrotizing (1)  ·  Hyperphagia (1)  ·  Systemic Inflammatory Response Syndrome (1)

Broader conditions

Hyperbilirubinemia (2)  ·  Jaundice (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Skin Manifestations (2)  ·  Bile Duct Diseases (1)  ·  Biliary Tract Diseases (1)  ·  Digestive System Diseases (1)  ·  Enterocolitis (1)  ·  Gastroenteritis (1)  ·  Gastrointestinal Diseases (1)  ·  Inflammation (1)  ·  Intestinal Diseases (1)  ·  Shock (1)

Interventions

Parenteral Nutrition (1)  ·  SMOFlipid (1)

Sponsors

University of Florida (1)  ·  Wanqing Gu (1)

Countries

China (1)  ·  United States (1)

Top investigators

Josef Neu, MD (1)